TipRanks

Joseph Andrew Walewicz Insider Profile

4 Followers
Joseph Andrew Walewicz, Chief Executive Officer at Neupath Health Inc., holds 1.23M shares in Neupath Health Inc. (Ticker: TSE:NPTH), holds 70.00K shares in Mirati Therapeutics (Ticker: MRTX).
tipranks
Joseph Andrew Walewicz

Joseph Andrew Walewicz
Neupath Health Inc. (NPTH)
Chief Executive Officer

Ranked #4,633 out of 109,193 Corporate Insiders

Profitable Transactions

83%
5 out of 6 Profitable Transactions

Average Return

+64.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

C$470K
100.00%
A breakdown of Joseph Andrew Walewicz's holdings

Insider Roles

Neupath Health Inc.
(NPTH)
Chief Executive Officer
Roles that Joseph Andrew Walewicz holds in companies

Most Profitable Insider Trade

Stock:
Neupath Health Inc.
(NPTH)
Rating:Informative Buy
Date:Dec 12, 2024 - Dec 12, 2025
Return:+168.40%
The most profitable trade made by Joseph Andrew Walewicz

Joseph Andrew Walewicz's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Neupath Health Inc.
Jun 13, 2026
Chief Executive Officer
Uninformative Buy
240.00K
C$666.81K
MRTX
Mirati Therapeutics
―
―
―
$4.11M
List of latest transactions for each holding click on a transaction to see Joseph Andrew Walewicz's performance on stock

Joseph Andrew Walewicz insider profile FAQ

What is the percentage of profitable transactions made by Joseph Andrew Walewicz?
The percentage of profitable transactions made by Joseph Andrew Walewicz is 83%.
    What is the average return per transaction made by Joseph Andrew Walewicz?
    The average return per transaction made by Joseph Andrew Walewicz is 64.50%.
      What stocks does Joseph Andrew Walewicz hold?
      Joseph Andrew Walewicz holds: TSE:NPTH, MRTX stocks.
        What was Joseph Andrew Walewicz’s latest transaction?
        Joseph Andrew Walewicz latest transaction was an Uninformative Buy of C$240.00K.
          What was Joseph Andrew Walewicz's most profitable transaction?
          Joseph Andrew Walewicz’s most profitable transaction was an Informative Buy of TSE:NPTH stock on December 12, 2024. The return on the trade was 168.40%.
            What is Joseph Andrew Walewicz's role in Neupath Health Inc.?
            Joseph Andrew Walewicz's role in Neupath Health Inc. is Chief Executive Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.